{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:27:03Z","timestamp":1790832423696,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00262-021-02870-2","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T15:00:15Z","timestamp":1613055615000},"page":"2529-2543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The liposome of trehalose dimycolate extracted from M.\u00a0bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells"],"prefix":"10.1007","volume":"70","author":[{"given":"Masanobu","family":"Shiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3618-0432","authenticated-orcid":false,"given":"Jun","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozaburo","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Nagumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Kandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-aki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuya","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"2","key":"2870_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/s0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116(2):180\u2013183. https:\/\/doi.org\/10.1016\/s0022-5347(17)58737-6","journal-title":"J Urol"},{"issue":"7597","key":"2870_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/s0140-6736(69)92648-8","volume":"1","author":"G Mathe","year":"1969","unstructured":"Mathe G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, De Vassal F (1969) Active immunotherapy for acute lymphoblastic leukaemia. Lancet 1(7597):697\u2013699. https:\/\/doi.org\/10.1016\/s0140-6736(69)92648-8","journal-title":"Lancet"},{"issue":"4","key":"2870_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","volume":"180","author":"DL Morton","year":"1974","unstructured":"Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketcham AS, Silverstein MJ, Sparks FC (1974) BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg 180(4):635\u2013643. https:\/\/doi.org\/10.1097\/00000658-197410000-00029","journal-title":"Ann Surg"},{"issue":"3","key":"2870_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","volume":"36","author":"MD Shelley","year":"2010","unstructured":"Shelley MD, Mason MD, Kynaston H (2010) Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 36(3):195\u2013205. https:\/\/doi.org\/10.1016\/j.ctrv.2009.12.005","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2870_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH (2014) The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective. Nat Rev Urol 11(3):153\u2013162. https:\/\/doi.org\/10.1038\/nrurol.2014.15","journal-title":"Nat Rev Urol"},{"issue":"2","key":"2870_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0006-3002(56)90289-x","volume":"20","author":"H Noll","year":"1956","unstructured":"Noll H, Bloch H, Asselineau J, Lederer E (1956) The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim Biophys Acta 20(2):299\u2013309. https:\/\/doi.org\/10.1016\/0006-3002(56)90289-x","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2870_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/iai.7.4.631-638.1973","volume":"7","author":"A Bekierkunst","year":"1973","unstructured":"Bekierkunst A, Yarkoni E (1973) Granulomatous hypersensitivity to trehalose-6,6\u2019-dimycolate (cord factor) in mice infected with BCG. Infect Immun 7(4):631\u2013638","journal-title":"Infect Immun"},{"issue":"13","key":"2870_CR8","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1084\/jem.20091750","volume":"206","author":"E Ishikawa","year":"2009","unstructured":"Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S (2009) Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206(13):2879\u20132888. https:\/\/doi.org\/10.1084\/jem.20091750","journal-title":"J Exp Med"},{"issue":"5","key":"2870_CR9","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.immuni.2013.03.010","volume":"38","author":"Y Miyake","year":"2013","unstructured":"Miyake Y, Toyonaga K, Mori D, Kakuta S, Hoshino Y, Oyamada A, Yamada H, Ono K, Suyama M, Iwakura Y, Yoshikai Y, Yamasaki S (2013) C-type lectin MCL is an FcRgamma-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity 38(5):1050\u20131062. https:\/\/doi.org\/10.1016\/j.immuni.2013.03.010","journal-title":"Immunity"},{"issue":"5","key":"2870_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/jnci\/55.5.1253","volume":"55","author":"EE Ribi","year":"1975","unstructured":"Ribi EE, Granger DL, Milner KC, Strain SM (1975) Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst 55(5):1253\u20131257. https:\/\/doi.org\/10.1093\/jnci\/55.5.1253","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2870_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/iai.24.2.586-588.1979","volume":"24","author":"E Yarkoni","year":"1979","unstructured":"Yarkoni E, Goren MB, Rapp HJ (1979) Effect of sulfolipid I on trehalose-6,6\u2019-dimycolate (cord factor) toxicity and antitumor activity. Infect Immun 24(2):586\u2013588","journal-title":"Infect Immun"},{"issue":"2","key":"2870_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/bf01742373","volume":"31","author":"Y Natsuhara","year":"1990","unstructured":"Natsuhara Y, Oka S, Kaneda K, Kato Y, Yano I (1990) Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. Cancer Immunol Immunother 31(2):99\u2013106. https:\/\/doi.org\/10.1007\/bf01742373","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"2870_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/s0006-2952(02)01346-1","volume":"64","author":"A Omri","year":"2002","unstructured":"Omri A, Suntres ZE, Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64(9):1407\u20131413. https:\/\/doi.org\/10.1016\/s0006-2952(02)01346-1","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2870_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1023\/a:1011080211226","volume":"18","author":"RM Schiffelers","year":"2001","unstructured":"Schiffelers RM, Storm G, Bakker-Woudenberg IA (2001) Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue. Pharm Res 18(6):780\u2013787. https:\/\/doi.org\/10.1023\/a:1011080211226","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"2870_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1081\/lpr-120039794","volume":"14","author":"P Stano","year":"2004","unstructured":"Stano P, Bufali S, Pisano C, Bucci F, Barbarino M, Santaniello M, Carminati P, Luisi PL (2004) Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J Liposome Res 14(1\u20132):87\u2013109. https:\/\/doi.org\/10.1081\/lpr-120039794","journal-title":"J Liposome Res"},{"issue":"1","key":"2870_CR16","doi-asserted-by":"publisher","first-page":"e0209196","DOI":"10.1371\/journal.pone.0209196","volume":"14","author":"T Yoshino","year":"2019","unstructured":"Yoshino T, Miyazaki J, Kojima T, Kandori S, Shiga M, Kawahara T, Kimura T, Naka T, Kiyohara H, Watanabe M, Yamasaki S, Akaza H, Yano I, Nishiyama H (2019) Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model. PLoS ONE 14(1):e0209196. https:\/\/doi.org\/10.1371\/journal.pone.0209196","journal-title":"PLoS ONE"},{"issue":"6","key":"2870_CR17","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1073\/pnas.0805177106","volume":"106","author":"S Yamasaki","year":"2009","unstructured":"Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mikami Y, Takeda K, Akira S, Saito T (2009) C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci U S A 106(6):1897\u20131902. https:\/\/doi.org\/10.1073\/pnas.0805177106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2870_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1158\/2326-6066.CIR-15-0176","volume":"4","author":"AJ Vandeveer","year":"2016","unstructured":"Vandeveer AJ, Fallon JK, Tighe R, Sabzevari H, Schlom J, Greiner JW (2016) Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res 4(5):452\u2013462. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0176","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"2870_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/IAI.69.2.810-815.2001","volume":"69","author":"H Yamagami","year":"2001","unstructured":"Yamagami H, Matsumoto T, Fujiwara N, Arakawa T, Kaneda K, Yano I, Kobayashi K (2001) Trehalose 6,6\u2019-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect Immun 69(2):810\u2013815. https:\/\/doi.org\/10.1128\/IAI.69.2.810-815.2001","journal-title":"Infect Immun"},{"issue":"20","key":"2870_CR20","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H (2019) PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc Natl Acad Sci U S A 116(20):9999\u201310008. https:\/\/doi.org\/10.1073\/pnas.1822001116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 10","key":"2870_CR21","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1099\/mic.0.28158-0","volume":"151","author":"Y Fujita","year":"2005","unstructured":"Fujita Y, Naka T, McNeil MR, Yano I (2005) Intact molecular characterization of cord factor (trehalose 6,6\u2019-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 151(Pt 10):3403\u20133416. https:\/\/doi.org\/10.1099\/mic.0.28158-0","journal-title":"Microbiology"},{"issue":"2","key":"2870_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, Kaisho T, Bogunovic D, Bhardwaj N, Krummel MF (2016) Critical Role for CD103(+)\/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. Cancer Cell 30(2):324\u2013336. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.003","journal-title":"Cancer Cell"},{"issue":"11","key":"2870_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","volume":"4","author":"JP Bottcher","year":"2018","unstructured":"Bottcher JP, Reis ESC (2018) The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity. Trends Cancer 4(11):784\u2013792. https:\/\/doi.org\/10.1016\/j.trecan.2018.09.001","journal-title":"Trends Cancer"},{"issue":"7","key":"2870_CR24","doi-asserted-by":"publisher","first-page":"e12833","DOI":"10.1111\/cmi.12833","volume":"20","author":"D Wang","year":"2018","unstructured":"Wang D, Gu X, Liu X, Wei S, Wang B, Fang M (2018) NK cells inhibit anti-Mycobacterium bovis BCG T cell responses and aggravate pulmonary inflammation in a direct lung infection mouse model. Cell Microbiol 20(7):e12833. https:\/\/doi.org\/10.1111\/cmi.12833","journal-title":"Cell Microbiol"},{"issue":"1","key":"2870_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/jb.100.1.95-102.1969","volume":"100","author":"A Bekierkunst","year":"1969","unstructured":"Bekierkunst A, Levij IS, Yarkoni E, Vilkas E, Adam A, Lederer E (1969) Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol 100(1):95\u2013102","journal-title":"J Bacteriol"},{"issue":"1","key":"2870_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.micpath.2007.02.006","volume":"43","author":"Y Fujita","year":"2007","unstructured":"Fujita Y, Okamoto Y, Uenishi Y, Sunagawa M, Uchiyama T, Yano I (2007) Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb Pathog 43(1):10\u201321. https:\/\/doi.org\/10.1016\/j.micpath.2007.02.006","journal-title":"Microb Pathog"},{"issue":"4","key":"2870_CR27","first-page":"371","volume":"36","author":"RL Hunter","year":"2006","unstructured":"Hunter RL, Olsen MR, Jagannath C, Actor JK (2006) Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36(4):371\u2013386","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"2870_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):102. https:\/\/doi.org\/10.1186\/1556-276X-8-102","journal-title":"Nanoscale Res Lett"},{"key":"2870_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13037","author":"M Kremenovic","year":"2020","unstructured":"Kremenovic M, Schenk M, Lee DJ (2020) Clinical and molecular insights into BCG immunotherapy for melanoma. J Intern Med. https:\/\/doi.org\/10.1111\/joim.13037","journal-title":"J Intern Med"},{"issue":"8","key":"2870_CR30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3109\/03639045.2014.954582","volume":"41","author":"H Shibata","year":"2015","unstructured":"Shibata H, Izutsu K, Yomota C, Okuda H, Goda Y (2015) Investigation of factors affecting in vitro doxorubicin release from PEGylated liposomal doxorubicin for the development of in vitro release testing conditions. Drug Dev Ind Pharm 41(8):1376\u20131386. https:\/\/doi.org\/10.3109\/03639045.2014.954582","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"2870_CR31","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1248\/cpb.33.4544","volume":"33","author":"F Numata","year":"1985","unstructured":"Numata F, Nishimura K, Ishida H, Ukei S, Tone Y, Ishihara C, Saiki I, Sekikawa I, Azuma I (1985) Lethal and adjuvant activities of cord factor (trehalose-6,6\u2019-dimycolate) and synthetic analogs in mice. Chem Pharm Bull (Tokyo) 33(10):4544\u20134555. https:\/\/doi.org\/10.1248\/cpb.33.4544","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"3","key":"2870_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0264-410x(89)90242-9","volume":"7","author":"T Sakurai","year":"1989","unstructured":"Sakurai T, Saiki I, Ishida H, Takeda K, Azuma I (1989) Lethal toxicity and adjuvant activities of synthetic TDM and its related compounds in mice. Vaccine 7(3):269\u2013274. https:\/\/doi.org\/10.1016\/0264-410x(89)90242-9","journal-title":"Vaccine"},{"issue":"1","key":"2870_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.20081445","volume":"206","author":"K Werninghaus","year":"2009","unstructured":"Werninghaus K, Babiak A, Gross O, Holscher C, Dietrich H, Agger EM, Mages J, Mocsai A, Schoenen H, Finger K, Nimmerjahn F, Brown GD, Kirschning C, Heit A, Andersen P, Wagner H, Ruland J, Lang R (2009) Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J Exp Med 206(1):89\u201397. https:\/\/doi.org\/10.1084\/jem.20081445","journal-title":"J Exp Med"},{"key":"2870_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2014.00288","volume":"5","author":"MB Richardson","year":"2014","unstructured":"Richardson MB, Williams SJ (2014) MCL and Mincle: C-Type Lectin Receptors That Sense Damaged Self and Pathogen-Associated Molecular Patterns. Front Immunol 5:288. https:\/\/doi.org\/10.3389\/fimmu.2014.00288","journal-title":"Front Immunol"},{"key":"2870_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","volume":"14","author":"S Farkona","year":"2016","unstructured":"Farkona S, Diamandis EP, Blasutig IM (2016) Cancer immunotherapy: the beginning of the end of cancer? BMC Med 14:73. https:\/\/doi.org\/10.1186\/s12916-016-0623-5","journal-title":"BMC Med"},{"issue":"9","key":"2870_CR36","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","volume":"125","author":"Y Yang","year":"2015","unstructured":"Yang Y (2015) Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest 125(9):3335\u20133337. https:\/\/doi.org\/10.1172\/JCI83871","journal-title":"J Clin Invest"},{"issue":"11","key":"2870_CR37","doi-asserted-by":"publisher","first-page":"e0206223","DOI":"10.1371\/journal.pone.0206223","volume":"13","author":"JW Yu","year":"2018","unstructured":"Yu JW, Bhattacharya S, Yanamandra N, Kilian D, Shi H, Yadavilli S, Katlinskaya Y, Kaczynski H, Conner M, Benson W, Hahn A, Seestaller-Wehr L, Bi M, Vitali NJ, Tsvetkov L, Halsey W, Hughes A, Traini C, Zhou H, Jing J, Lee T, Figueroa DJ, Brett S, Hopson CB, Smothers JF, Hoos A, Srinivasan R (2018) Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. PLoS ONE 13(11):e0206223. https:\/\/doi.org\/10.1371\/journal.pone.0206223","journal-title":"PLoS ONE"},{"issue":"7528","key":"2870_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature13988","volume":"515","author":"MM Gubin","year":"2014","unstructured":"Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD (2014) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515(7528):577\u2013581. https:\/\/doi.org\/10.1038\/nature13988","journal-title":"Nature"},{"issue":"10","key":"2870_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/2326-6066.CIR-16-0060","volume":"4","author":"B Homet Moreno","year":"2016","unstructured":"Homet Moreno B, Zaretsky JM, Garcia-Diaz A, Tsoi J, Parisi G, Robert L, Meeth K, Ndoye A, Bosenberg M, Weeraratna AT, Graeber TG, Comin-Anduix B, Hu-Lieskovan S, Ribas A (2016) Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells. Cancer Immunol Res 4(10):845\u2013857. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0060","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"2870_CR40","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk M, Burger M, Comperat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Roupret M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernandez V, Peyronnet B, Seisen T, Soukup V (2019) European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)\u20142019 Update. Eur Urol 76(5):639\u2013657. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.016","journal-title":"Eur Urol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-02870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-021-02870-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-02870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T12:07:00Z","timestamp":1628770020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-021-02870-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2870"],"URL":"https:\/\/doi.org\/10.1007\/s00262-021-02870-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"8 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All animal care and experimental procedures were performed in accordance with national and regional legislation on animal protection, and all animal procedures were consistent with the University of Tsukuba's Regulation of Animal Experiments and were approved by the Animal Experiment Committee, University of Tsukuba.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}